Ali Tavassoli

Ali Tavassoli is an accomplished academic and industry leader in the field of chemical biology. Currently serving as the Chief Scientific Officer at Curve Therapeutics Limited since July 2019, Ali Tavassoli has also held various academic positions at the University of Southampton since October 2006, including Professor, Reader, and Lecturer in Chemical Biology. As President of the Chemistry & Biology Interface Division of the Royal Society of Chemistry from July 2020 to July 2023, Ali Tavassoli contributed to the advancement of interdisciplinary collaboration. Prior postdoctoral experiences include research in chemical biology at Penn State University under the mentorship of Professor Stephen J and in biological chemistry at the University of Sussex with Professor Douglas W. Ali Tavassoli holds a Bachelor’s degree in Chemistry from the University of Bristol and a Ph.D. in Organic Chemistry from the University of Reading.